GGrantIndex
Sort

53,477 grants matching addiction

Stress, Arousal and Mood: Affective Influences on Decisions under Uncertainty

$567,818
Elizabeth A. Phelps · Harvard University · R01 · FY2019 · DA

Selegiline Patch for Treatment of Nicotine Dependence

$567,811
Joel D Killen · Stanford University · R01 · FY2006 · DA

Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment

$567,763
Todd D Gould · University Of Maryland Baltimore · R01 · FY2019 · MH

Alcohol treatment in Medicaid managed care plans: Disparities in policies and outcomes

$567,721
Maureen T Stewart · Boston University Medical Campus · R01 · FY2025 · AA

The prefrontal cortex in salience and control in cocaine addiction: phFMRI study

$567,704
Rita Z Goldstein · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2011 · DA

OFFICE BASED METHADONE PRESCRIBING II

$567,686
Montefiore Medical Center (Bronx, Ny) · R01 · FY2001 · DA

Varenicline OTC Trial on Efficacy and Safety

$567,681
Scott J Leischow · Arizona State University-Tempe Campus · R01 · FY2019 · DA

Understanding how opioids affect the experiential and neural signatures of feelings of social connection with close others

$567,615
Tristen K. Inagaki · San Diego State University · R01 · FY2021 · DA

REST-mediated regulation of opioid receptors in chronic pain mouse models

$567,612
Sadhan Majumder · University Of Tx Md Anderson Can Ctr · R33 · FY2024 · DA

REST-mediated regulation of opioid receptors in chronic pain mouse models

$567,612
Sadhan Majumder · University Of Tx Md Anderson Can Ctr · R33 · FY2025 · DA

Endocannabinoid and other brain receptor systems roles in neurochemical and reinforcing effects of abused drugs

$567,586
Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2020 · DA

Adoption of Buprenorphine in an HMO Setting

$567,578
Dennis McCarty · Oregon Health & Science University · R01 · FY2007 · DA

IV COCAINE ABUSE TREATMENT: A LABORATORY MODEL

$567,564
Columbia University Health Sciences · R01 · FY2002 · DA

Gestational Age Variation in Human Placental Transport Mechanisms

$567,465
Laura Goetzl · Temple Univ Of The Commonwealth · R01 · FY2014 · HD

Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis

$567,462
Richard B. Markham · Johns Hopkins University · R01 · FY2012 · DA

ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...

$567,357
Mary J Kreek · Rockefeller University · P60 · FY2011 · DA

Succinylation and Malonylation as Novel Protein Modifications in Cancer

$567,328
Hening Lin · Cornell University · R01 · FY2013 · CA

Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation

$567,312
Sabita Roy · University Of Minnesota · R01 · FY2014 · DA

Extending Drug Abuse Treatment & Assessment Resources (DATAR5)

$567,304
Patrick M Flynn · Texas Christian University · R01 · FY2010 · DA

Selegiline Patch for Treatment of Nicotine Dependence

$567,300
Stanford University · R01 · FY2003 · DA

GENOME RESPONSES TO DROSOPHILA ADDICTION USING DNA CHIPS

$567,290
Cold Spring Harbor Laboratory · R01 · FY2000 · DA

Neural substrates of opiate-HIV interactions.

$567,213
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2020 · DA

Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine Addiction

$567,207
Paul Whiteaker · St. Joseph'S Hospital And Medical Center · R01 · FY2017 · DA

Novel Medications for Cannabis Dependence

$567,200
Alexandros Makriyannis · Northeastern University · R01 · FY2011 · DA

Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences

$567,172
Rangan Maitra · Research Triangle Institute · R01 · FY2022 · DA